The $360 Billion Market that Medicine Got Wrong for 20 Years
Original Report
The $360 billion dollar women’s health market is made of several categories that are often overlooked – one of which is menopause. The condition has gone largely unnoticed by pharma and biotech...
The $360 billion dollar women’s health market is made of several categories that are often overlooked – one of which is menopause. The condition has gone largely unnoticed by pharma and biotech firms, employers, and investors, despite affecting half the world’s population and contributing to major losses in productivity. That is starting to change as celebrities like Naomi Watts, startups such as Stripes and Midi Health, and investors including Amboy Street Ventures turn women’s midlife health into a fast-growing market. The shift has accelerated alongside the FDA’s rollback of long-standing warnings on hormone replacement therapy. But as the category grows, so does the challenge for women trying to distinguish evidence-based care from unproven wellness products and marketing hype. (Source: Bloomberg)
Glass House Analysis
This story reflects the interconnected nature of modern economic systems, where developments in one sector inevitably affect others. Understanding these connections is essential for grasping how policy decisions and market movements translate into real-world outcomes for families, workers, and communities. The economy is not an abstract system of numbers—it's the sum total of decisions about who works, who prospers, and who struggles.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Elon Musk and Sam Altman spar on X after Apple files OpenAI lawsuit
Sam Altman insisted that Elon Musk was again obsessed with him because of an OpenAI model release earlier this week.